2Y8-20040-27768 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2020-12-25
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Muscle or body aches

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-30
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-07
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-11
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-10
Survey response — 12 months, dose 2
MedDRA: Hyperemesis gravidarum, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Pregnancy, hyperemesis gravidarium

MedDRA releases: 2024-11 · check-in free text available
2022-01-10
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-01-11
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-09	priority 2/3
2022-01-10	Unsuccessful

Free text

Release 10 — 12 months, dose 2

2022-01-10

Symptoms: Pregnancy, hyperemesis gravidarium

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Hyperemesis gravidarum	·	·	✓
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release